GSK plc
GSK
$51.84
-$0.53-1.01%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.84% | 40.81% | -5.76% | 285.78% | 802.46% |
| Total Depreciation and Amortization | -183.66% | -35.72% | 49.36% | 302.68% | -79.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,250.14% | 54.75% | -194.16% | -95.14% | 584.01% |
| Change in Net Operating Assets | 181.93% | -18.05% | 68.26% | -187.44% | -128.33% |
| Cash from Operations | 1.12% | 7.01% | 94.15% | -51.65% | 6.41% |
| Capital Expenditure | -81.72% | -22.63% | -30.54% | 62.40% | -75.53% |
| Sale of Property, Plant, and Equipment | 156.45% | 0.94% | 430.31% | -98.39% | 5,903.24% |
| Cash Acquisitions | 95.07% | -28,836.49% | 99.60% | -1,114.95% | -1,499.22% |
| Divestitures | -1.36% | 103.61% | -2,869.69% | 80.33% | -64.02% |
| Other Investing Activities | 10.80% | -7.71% | -173.53% | 76.89% | -32.62% |
| Cash from Investing | 39.89% | -147.27% | 42.05% | -0.54% | -50.65% |
| Total Debt Issued | 790.00% | -112.40% | -68.95% | 54.88% | -- |
| Total Debt Repaid | -27.42% | 96.06% | -627.78% | 81.27% | -90.89% |
| Issuance of Common Stock | -- | -100.00% | -83.33% | -- | -100.00% |
| Repurchase of Common Stock | 20.50% | 43.49% | -127.13% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.97% | -0.02% | -13.69% | 1.65% | 1.59% |
| Other Financing Activities | -109.71% | 10.43% | -47.44% | 62.68% | -1,572.00% |
| Cash from Financing | 35.80% | 44.04% | -393.22% | 200.21% | 33.17% |
| Foreign Exchange rate Adjustments | -168.54% | 329.06% | -150.69% | -254.54% | 120.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.21% | 38.48% | -215.94% | 122.39% | 147.68% |